Literature DB >> 10652447

Expression and function of the protein tyrosine phosphatase SHP-1 in oligodendrocytes.

P T Massa1, S Saha, C Wu, K W Jarosinski.   

Abstract

Previous studies in this laboratory have shown that the SH-2 domain-containing protein tyrosine phosphatase SHP-1 is expressed in CNS glia and functions to modulate cytokine activities in these cells. The present study demonstrates that SHP-1 is expressed within multiple regions of the CNS in vivo, especially in white matter. Interestingly, we show that mice genetically lacking in SHP-1 (motheaten mice) in the CNS displayed dysmyelination. We therefore examined the expression of SHP-1 in the myelin-forming oligodendrocytes. Oligodendrocytes present in either mixed glial cultures or pure cultures expressed high levels of SHP-1 in the cytoplasm of cell bodies and processes. Oligodendrocytes isolated from motheaten mice did not express SHP-1. To test possible functions for SHP-1 in oligodendrocytes in controlling cytokine signaling, we compared the responsiveness of oligodendrocytes isolated from either motheaten or normal littermate mice with IL-6. IL-6 induced higher levels of STAT3 phosphorylation and STAT3-responsive c-fos gene expression in pure oligodendrocyte cultures of motheaten compared with normal littermate mice. These studies demonstrate that oligodendrocytes express SHP-1 and that SHP-1 functions to control IL-6 signaling. SHP-1 may therefore be a critical regulator of oligodendrocyte differentiation in response to IL-6 family cytokines. Further, these findings may relate to dysmyelination in mice lacking SHP-1. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10652447

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  30 in total

Review 1.  Functional expression and localization of P-glycoprotein in the central nervous system: relevance to the pathogenesis and treatment of neurological disorders.

Authors:  Gloria Lee; Reina Bendayan
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

Review 2.  Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions.

Authors:  Jean-Luc Dreyer
Journal:  Mol Biotechnol       Date:  2011-02       Impact factor: 2.695

Review 3.  The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury.

Authors:  Z Z Chong; K Maiese
Journal:  Histol Histopathol       Date:  2007-11       Impact factor: 2.303

4.  Promoter-specific induction of the phosphatase SHP-1 by viral infection and cytokines in CNS glia.

Authors:  George P Christophi; Chad A Hudson; Ross Gruber; Christoforos P Christophi; Paul T Massa
Journal:  J Neurochem       Date:  2008-06-01       Impact factor: 5.372

5.  Induction of IL-33 expression and activity in central nervous system glia.

Authors:  Chad A Hudson; George P Christophi; Ross C Gruber; Joel R Wilmore; David A Lawrence; Paul T Massa
Journal:  J Leukoc Biol       Date:  2008-06-13       Impact factor: 4.962

6.  The control of reactive oxygen species production by SHP-1 in oligodendrocytes.

Authors:  Ross C Gruber; Daria LaRocca; Scott B Minchenberg; George P Christophi; Chad A Hudson; Alex K Ray; Bridget Shafit-Zagardo; Paul T Massa
Journal:  Glia       Date:  2015-04-27       Impact factor: 7.452

7.  SHP-1 deficiency and increased inflammatory gene expression in PBMCs of multiple sclerosis patients.

Authors:  George P Christophi; Chad A Hudson; Ross C Gruber; Christoforos P Christophi; Cornelia Mihai; Luis J Mejico; Burk Jubelt; Paul T Massa
Journal:  Lab Invest       Date:  2008-01-21       Impact factor: 5.662

8.  Modulation of macrophage infiltration and inflammatory activity by the phosphatase SHP-1 in virus-induced demyelinating disease.

Authors:  George P Christophi; Chad A Hudson; Michael Panos; Ross C Gruber; Paul T Massa
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

9.  The control of oligodendrocyte bioenergetics by interferon-gamma (IFN-γ) and Src homology region 2 domain-containing phosphatase-1 (SHP-1).

Authors:  Scott B Minchenberg; Paul T Massa
Journal:  J Neuroimmunol       Date:  2017-10-28       Impact factor: 3.478

10.  Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype.

Authors:  George P Christophi; Michael Panos; Chad A Hudson; Rebecca L Christophi; Ross C Gruber; Akos T Mersich; Scott D Blystone; Burk Jubelt; Paul T Massa
Journal:  Lab Invest       Date:  2009-04-27       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.